Analysts Set Silence Therapeutics plc (NASDAQ:SLN) PT at $45.00
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven research firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 1 year […]
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven research firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 1 year […]
